AGIO · Agios Pharmaceuticals, Inc. · Executive Compensation
Market Cap
$2.01B
Shares
59.70M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Brian Goff | Chief Executive Officer | $5,370,389 |
| Krishnan Viswanadhan | Pharm.D Chief Corporate Development & Strategy Officer | $2,805,026 |
| Cecilia Jones | Chief Financial Officer | $2,518,222 |
| James Burns | Chief Legal Officer | $2,369,416 |
| Sarah Gheuens | M.D., Ph.D. Chief Medical Officer, Head of Research & Development | $2,086,680 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Brian Goff | Chief Executive Officer | $6,776,359 |
| Sarah Gheuens | M.D., Ph.D. Chief Medical Officer, Head of Research & Development | $2,544,347 |
| Tsveta Milanova | Chief Commercial Officer | $2,453,418 |
| James Burns | Chief Legal Officer | $2,432,507 |
| Cecilia Jones | Chief Financial Officer | $2,419,349 |
| Krishnan Viswanadhan | Pharm.D Chief Corporate Development & Strategy Officer | — |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Tsveta Milanova | Chief Commercial Officer | $3,733,273 |
| Brian Goff | Chief Executive Officer | $3,416,453 |
| Sarah Gheuens | M.D., Ph.D. Chief Medical Officer, Head of Research & Development | $2,870,159 |
| James Burns | Chief Legal Officer | $1,934,540 |
| Cecilia Jones | Chief Financial Officer | $1,208,784 |
| Krishnan Viswanadhan | Pharm.D Chief Corporate Development & Strategy Officer | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Brian Goff | Chief Executive Officer | $11,744,447 |
| Jacqualyn Fouse | Former Chief Executive Officer | $4,911,049 |
| Cecilia Jones | Chief Financial Officer | $2,910,926 |
| Richa Poddar | Former Chief Commercial Officer | $1,926,456 |
| Bruce Car | Former Chief Scientific Officer | $1,852,384 |
| Sarah Gheuens | M.D., Ph.D. Chief Medical Officer, Head of Research & Development | $1,846,903 |
| James Burns | Chief Legal Officer | $1,738,025 |
| Jonathan Biller | Former Chief Financial Officer, Head of Corporate Affairs | $1,478,067 |
| Tsveta Milanova | Chief Commercial Officer | — |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Jacqualyn Fouse | Former Chief Executive Officer | $6,519,427 |
| Jonathan Biller | Former Chief Financial Officer, Head of Corporate Affairs | $2,832,035 |
| Bruce Car | Former Chief Scientific Officer | $2,803,973 |
| Christopher Bowden | Former Chief Medical Officer | $2,774,889 |
| Darrin Miles | — | $2,473,768 |
| Sarah Gheuens | M.D., Ph.D. Chief Medical Officer, Head of Research & Development | $1,169,510 |
| Richa Poddar | Former Chief Commercial Officer | $1,074,744 |
| Tsveta Milanova | Chief Commercial Officer | — |
| Cecilia Jones | Chief Financial Officer | — |
| James Burns | Chief Legal Officer | — |
| Brian Goff | Chief Executive Officer | — |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Jacqualyn Fouse | Former Chief Executive Officer | $7,611,975 |
| Bruce Car | Former Chief Scientific Officer | $3,228,043 |
| Christopher Bowden | Former Chief Medical Officer | $2,894,546 |
| Andrew Hirsch | — | $2,886,122 |
| Jonathan Biller | Former Chief Financial Officer, Head of Corporate Affairs | $769,328 |
| Sarah Gheuens | M.D., Ph.D. Chief Medical Officer, Head of Research & Development | — |
| Brian Goff | Chief Executive Officer | — |
| Former Chief CommercialOfficer | — | — |
| Richa Poddar | Former Chief Commercial Officer | — |
| Cecilia Jones | Chief Financial Officer | — |
| James Burns | Chief Legal Officer | — |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Jacqualyn Fouse | Chief Executive Officer | $16,607,994 |
| Former Chief FinancialOfficer | — | $4,248,831 |
| Andrew Hirsch | Chief Financial Officer | $4,248,831 |
| Christopher Bowden | Former Chief Medical Officer | $3,227,208 |
| Scott Biller | Chief Scientific Officer | $3,206,140 |
| Jonathan Biller | Chief Financial Officer, Head of CorporateAffairs | $3,183,889 |
| David P. Schenkein | Former President and ChiefExecutiveOfficer;Executive Chairman | $2,576,376 |
| Richa Poddar | Chief Commercial Officer | — |
| Former Chief CommercialOfficer | — | — |
| Sarah Gheuens | M.D., Ph.D. Chief Medical Officer | — |
| Bruce Car | Chief Scientific Officer | — |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| David P. Schenkein | Former President and ChiefExecutiveOfficer;Executive Chairman | $8,199,324 |
| Andrew Hirsch | Chief Financial Officer | $3,136,858 |
| Former Chief FinancialOfficer | — | $3,136,858 |
| Christopher Bowden | Chief Medical Officer | $3,128,730 |
| Scott Biller | Chief Scientific Officer | $3,098,054 |
| Jacqualyn Fouse | Chief Executive Officer | — |
| Jonathan Biller | Chief Legal Officer | — |
| Bruce Car | Chief Scientific Officer | — |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| David P. Schenkein | Former President and ChiefExecutiveOfficer;Executive Chairman | $5,972,364 |
| Christopher Bowden | Chief Medical Officer | $2,330,808 |
| Andrew Hirsch | Chief Financial Officer | $2,320,055 |
| Scott Biller | Chief Scientific Officer | $2,301,877 |
| Jacqualyn Fouse | Chief Executive Officer | — |
| Jonathan Biller | Chief Financial Officer, Head of Legal andCorporate Affairs | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Cynthia Smith | Class I director | Appointed | 2026-06-18 |
| Brian Goff | Class I director | Appointed | 2026-06-18 |
| Rahul Ballal, Ph.D. | Class I director | Appointed | 2026-06-18 |
| Jay Backstrom, M.D., MPH | director | Appointed | 2025-07-08 |
| David Scadden, M.D. | Class III director | Appointed | 2025-06-18 |
| Jacqualyn A. Fouse, Ph.D. | Class III director | Appointed | 2025-06-18 |
| David P. Schenkein | Board of Directors | Resigned | 2025-02-13 |
Key facts
CIK
1439222
CUSIP
00847X104
13F (30d)
122 filings
121 filers
Visit website
Investor relations